Effects of Dietary Interventions on the Aging Brain
- Conditions
- Healthy
- Interventions
- Behavioral: Caloric restrictionDietary Supplement: Omega-3 (fish oil capsules)Dietary Supplement: ResveratrolDietary Supplement: Placebo
- Registration Number
- NCT00996229
- Lead Sponsor
- University Hospital Muenster
- Brief Summary
The researchers will investigate whether caloric restriction or dietary supplementation could provide positive effects on general brain functions in healthy elderly people.
- Detailed Description
The age-related degradation of cognitive functions even to the point of neurodegenerative disorders such as Alzheimer's disease are a growing public-health concern with devastating effects.
Referring to animal data, empirical studies, and pilot human trials, a healthy diet rich in unsaturated fatty acids and low in calories should improve cognitive functions such as learning and memory. To test this hypothesis, the researchers study general brain functions in healthy elderly subjects (50-80 years old) during a short term diet.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
- healthy subjects
- 50-80 years old
- moderate to heavy weight (BMI 25-30)
- must be able to change diet/take supplements at home
- diabetes
- younger than 50 years
- BMI < 25
- psychiatric medication
- severe disease
- MMSE < 26
- eating disorders
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Caloric restriction + placebo supplementation Caloric restriction - Caloric restriction + placebo supplementation Placebo - Omega-3 supplementation Omega-3 (fish oil capsules) - Placebo supplementation Placebo - Resveratrol supplementation Resveratrol -
- Primary Outcome Measures
Name Time Method Auditory verbal Learning Task Baseline (timepoint 0), after 6 months (timepoint 6 months)
- Secondary Outcome Measures
Name Time Method Functional/Structural brain changes Baseline (timepoint 0), after 6 months (timepoint 6 months) Plasma biomarkers Baseline (timepoint 0), after 6 months (timepoint 6 months)f intervention
Trial Locations
- Locations (1)
Department of Neurology, Charité Universitätsmedizin Berlin
🇩🇪Berlin, Germany